Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to 'kratom'
- PMID: 30149482
- PMCID: PMC6484255
- DOI: 10.3233/NPM-1863
Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to 'kratom'
Abstract
Background: Mitragyna speciosa, also known as kratom, is obtained from the coffee plant family 'Rubiaceae.' Kratom is available in the form of capsules, whole, processed and powdered leaves, and as liquids. Secondary to its 'natural herb' status and opioid effects, it is misconceived to be a safe alternative for the treatment of chronic pain. The use of kratom has increased by tenfold in the United States since 2010.
Methods and results: We report a term neonate who was born to a chronic kratom user and required treatment with opiates for neonatal drug withdrawal.
Conclusion: Physicians should be aware of these herbal supplements and its potential withdrawal effects in newborn which cannot be picked up by the standard toxicology screen.
Keywords: Kratom; NAS – neonatal abstinence syndrome.
Conflict of interest statement
None.
Figures
References
-
- Creanga AA, Sabel JC, Ko JY et al. Maternal drug use and its effect on neonates: A population-based study in Washington State. Obstet Gynecol. 2012;119(5):924–33. - PubMed
-
- Hudak ML, Tan RC, Committee On D, Committee On F, Newborn, American Academy of P. Neonatal drug withdrawal. Pediatrics. 2012;129(2):e540–60. - PubMed
-
- Results from the 2015 National Survey On Drug UseAnd Health: Detailed Tables. https://wwwsamhsagov/data/sites/default/files/NSDUH-DetTabs-/NSDUH-DetTa....
-
- Trakulsrichai S, Tongpo A, Sriapha C et al. Kratom abuse in Ramathibodi Poison Center, Thailand: A five-year experience. J Psychoactive Drugs. 2013;45(5):404–8. - PubMed
-
- Voelker R.Kratom Products Seized. JAMA. 2016;316(11):1142. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
